Table 11 Summary statistics for surgery for patients with any response to systemic therapy
From: The cost of unresectable stage III or stage IV melanoma in Italy
Overall | First-line therapy | Second-line therapy | Third-line therapy | ||
|---|---|---|---|---|---|
N | 89 | 53 | 34 | 14 | |
Patients with any surgery | N | 27 | 13 | 8 | 2 |
% | 30,3% | 24,5% | 23,5% | 14,3% | |
Type of surgery | |||||
Resection of primary tumor | % | 6% | 6% | 0% | 0% |
Lymph node resection | % | 11% | 7% | 1% | 1% |
All other visceral | % | 12% | 5% | 4% | 0% |
Brain metastases | % | 5% | 3% | 1% | 1% |
Isolated limb perfusion | % | 0% | 0% | 0% | 0% |
Biopsy | % | 6% | 3% | 1% | 0% |
Distant skin, subcutaneous or node | % | 5% | 3% | 1% | 0% |
Lung | % | 1% | 1% | 0% | 0% |
Total surgery cost per patient with any surgery (€ 2009) | Mean | 7.621 | 9.070 | 5.778 | 7.426 |
Total surgery cost per patient (€ 2009) | Mean | 2.312 | 2.225 | 1.360 | 1.061 |